News | March 10, 2026
Avio Smart teams up with Huwel Lifesciences to roll out next-gen molecular diagnostics in India
Huwel’s diagnostic solutions leverage open RT-PCR system
Huwel’s diagnostic solutions leverage open RT-PCR system
The FDA decision was based on results from the pivotal POETYK PsA-1 and POETYK PsA-2 Phase 3 trials
ABBV-295 produced clinically meaningful, dose-dependent weight loss over 12–13 weeks
The conditional, time-limited approval comes through a joint effort with RACTHERA, a joint venture in which Sumitomo Chemical holds a 66.6% stake and Sumitomo Pharma holds 33.4%
DiaMedica said it plans to launch the trial later in 2026
The company says those insights can power advanced analytics and real-world evidence (RWE), helping researchers improve trial design, study feasibility, and recruitment strategies
Gazyva/Gazyvaro outperformed placebo across all key and secondary endpoints
The company announced positive topline data from the Phase II ZUPREME-1 trial
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
Subscribe To Our Newsletter & Stay Updated
